-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of "Buy" by Brokerages
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Average Rating of "Buy" by Brokerages
Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) have been assigned a consensus recommendation of "Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $73.50.
Several research firms recently commented on MMSI. Raymond James upped their price objective on Merit Medical Systems from $71.00 to $72.00 and gave the company an "outperform" rating in a research note on Thursday, October 27th. Canaccord Genuity Group cut Merit Medical Systems from a "buy" rating to a "hold" rating and reduced their target price for the company from $73.00 to $72.00 in a research note on Tuesday, December 20th. StockNews.com upgraded shares of Merit Medical Systems from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, January 3rd. Canaccord Genuity Group increased their target price on shares of Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. Finally, Piper Sandler increased their target price on shares of Merit Medical Systems from $70.00 to $73.00 in a report on Thursday, October 27th.
Get Merit Medical Systems alerts:Institutional Trading of Merit Medical Systems
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. MinichMacGregor Wealth Management LLC purchased a new stake in Merit Medical Systems in the 4th quarter worth about $26,000. Ronald Blue Trust Inc. grew its stake in Merit Medical Systems by 157.4% in the 4th quarter. Ronald Blue Trust Inc. now owns 471 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 288 shares in the last quarter. Lindbrook Capital LLC boosted its stake in shares of Merit Medical Systems by 148.4% during the second quarter. Lindbrook Capital LLC now owns 477 shares of the medical instruments supplier's stock valued at $26,000 after purchasing an additional 285 shares in the last quarter. CWM LLC boosted its stake in shares of Merit Medical Systems by 65.6% during the third quarter. CWM LLC now owns 593 shares of the medical instruments supplier's stock valued at $34,000 after purchasing an additional 235 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in shares of Merit Medical Systems during the first quarter valued at approximately $43,000. 95.38% of the stock is currently owned by institutional investors.
Merit Medical Systems Stock Up 1.1 %
Shares of MMSI opened at $70.23 on Monday. The company has a market capitalization of $4.00 billion, a PE ratio of 65.03, a PEG ratio of 2.26 and a beta of 1.01. Merit Medical Systems has a 12 month low of $50.46 and a 12 month high of $76.14. The stock's 50-day moving average price is $70.76 and its two-hundred day moving average price is $63.08. The company has a current ratio of 2.35, a quick ratio of 1.19 and a debt-to-equity ratio of 0.19.Merit Medical Systems (NASDAQ:MMSI – Get Rating) last issued its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.11. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. The business had revenue of $287.18 million during the quarter, compared to analyst estimates of $273.03 million. On average, analysts anticipate that Merit Medical Systems will post 2.57 EPS for the current year.
Merit Medical Systems Company Profile
(Get Rating)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
Further Reading
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
据Marketbeat.com报道，目前跟踪该股票的8位分析师一致建议买入默瑞特医疗系统公司的股票(纳斯达克代码：MMSI-GET Rating)。一位分析师对该股的评级为持有，两位分析师给出了买入评级，一位分析师给出了该公司强烈的买入评级。在过去一年对该股进行评级的券商中，12个月目标价平均为73.50美元。
几家研究公司最近对MMSI发表了评论。雷蒙德·詹姆斯在10月27日星期四的一份研究报告中将Merit Medical Systems的目标价从71.00美元上调至72.00美元，并给予该公司“跑赢大盘”的评级。在12月20日星期二的一份研究报告中，Canaccel Genuity Group将Merit Medical Systems的评级从“买入”下调至“持有”，并将该公司的目标价从73.00美元下调至72.00美元。在1月3日周二的一份研究报告中，StockNews.com将Merit Medical Systems的股票评级从“买入”上调至“强力买入”。在11月7日星期一的一份报告中，Canaccel Genuity Group将Merit Medical Systems的股票目标价从69.00美元上调至73.00美元。最后，Piper Sandler在10月27日星期四的一份报告中将Merit医疗系统公司的股票目标价从70.00美元上调至73.00美元。
到达优点医疗系统警报：功勋医疗系统的制度性交易
一些机构投资者和对冲基金最近买卖了该股的股票。MinichMacGregor Wealth Management LLC在第四季度购买了Merit Medical Systems的新股份，价值约2.6万美元。罗纳德·布鲁信托公司在第四季度增持了157.4%的Merit医疗系统股份。罗纳德·布鲁信托公司(Ronald Blue Trust Inc.)在上个季度增持了288股后，现在持有这家医疗器械供应商471股股票，价值2.6万美元。Lindbrook Capital LLC在第二季度增持了148.4%的Merit Medical Systems股票。Lindbrook Capital LLC现在持有这家医疗器械供应商477股股票，价值2.6万美元，上个季度又购买了285股。Cwm LLC在第三季度将其在Merit Medical Systems的股份增加了65.6%。Cwm LLC现在持有这家医疗器械供应商593股股票，价值3.4万美元，上个季度又购买了235股。最后，Quantbot Technologies LP在第一季度购买了价值约4.3万美元的Merit医疗系统公司的新股票。95.38%的股票目前由机构投资者持有。
优点医疗系统公司股票上涨1.1%
周一，MMSI的股价开盘报70.23美元。该公司市值为4亿美元，市盈率为65.03倍，聚乙二醇率为2.26倍，贝塔系数为1.01。优点医疗系统公司的12个月低点为50.46美元，12个月高位为76.14美元。该股的50日移动均线价格为70.76美元，200日移动均线价格为63.08美元。该公司的流动比率为2.35，速动比率为1.19，债务权益比率为0.19。优点医疗系统公司(纳斯达克代码：MMSI-GET Rating)最近一次发布财报是在10月26日星期三。这家医疗器械供应商公布本季度每股收益为0.64美元，比分析师普遍预期的0.53美元高出0.11美元。优点医疗系统公司的股本回报率为14.14%，净利润率为5.43%。该业务本季度营收为2.8718亿美元，而分析师预期为2.7303亿美元。分析师平均预计，Merit Medical Systems本年度的每股收益将达到2.57美元。
优点医疗系统公司简介
(获取评级)
优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品，主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。
进一步阅读
- 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
- 市场回顾周-1/16-1/20
- Old Dominion是否表明Trucking正在踩刹车？
- 诺德斯特龙对零售业降价的担忧
- 埃克森美孚股票：在Buy Point附近
- 高股息率的必和必拓认为中国推动了23年的增长
接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧